Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine
Background. In late October 2009, school-located pandemic vaccination was initiated in Maine before or concurrent with 2009 pandemic influenza A (H1N1) virus (pH1N1) peak activity. Methods. A case-control evaluation of 2009 H1N1 vaccine effectiveness was conducted in schools in Cumberland County, Ma...
Gespeichert in:
| Veröffentlicht in: | The Journal of infectious diseases 2012-10, Vol.206 (7), p.1059-1068 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1068 |
|---|---|
| container_issue | 7 |
| container_start_page | 1059 |
| container_title | The Journal of infectious diseases |
| container_volume | 206 |
| creator | Uzicanin, Amra Thompson, Mark Smith, Peter Chaves, Sandra S. Foster, Lydia Dube, Nancy Graitcer, Samuel Jackson, Rebel Ferdinands, Jill Gargiullo, Paul Mills, Dora Monto, Arnold S. Shay, David K. |
| description | Background. In late October 2009, school-located pandemic vaccination was initiated in Maine before or concurrent with 2009 pandemic influenza A (H1N1) virus (pH1N1) peak activity. Methods. A case-control evaluation of 2009 H1N1 vaccine effectiveness was conducted in schools in Cumberland County, Maine. A case was a child who had an acute respiratory illness during 2 November-18 December 2009, and who tested positive for pH1N1 by real-time reverse-transcription polymerase chain reaction (rRT-PCR). For each case, ≥4 event time-matched controls were sampled among classmates present in school during the study period who did not have an influenza-like illness. Vaccine effectiveness was calculated as (1 - adjusted odds ratio [aOR]) × 100%; aOR was estimated by using weighted logistic regression. Results. After adjusting for a diagnosis of asthma, 1 dose of 2009 H1N1 vaccine provided 69% protection (95% confidence interval (CI), 13-89) against rRT-PCR-confirmed H1N1 infection. Vaccine effectiveness estimates for live attenuated and inactivated vaccine were 81% (95% CI, -37 to 97), and 58% (95% CI: -39 to 87), respectively. Conclusions. One dose of monovalent pandemic vaccine provided substantial protection against pH1N1 infection among school-aged children. |
| doi_str_mv | 10.1093/infdis/jis441 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1642623797</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>41725718</jstor_id><sourcerecordid>41725718</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-d2b16ec14d49c43e8eecba33ff47b9e7f5dc7b88630fb7fd92bbd2aa827ddd6a3</originalsourceid><addsrcrecordid>eNqFkU9v1DAQxSMEokvhyBHkC1I5hPpPYsfHVWhppRZQKVwjxx53vcraWztbqXy7fjMcsuyV04w0v_eeNK8o3hL8iWDJTp23xqXTtUtVRZ4VC1IzUXJO2PNigTGlJWmkPCpepbTGGFeMi5fFEaVNjQnFi-LpzFrQo3sADymhYBFBn0OCabv0dtiB_63QEp1ckK_kI6IYS3QdfHhQA_gR_VJau6xEzqPvEbLL6PwduslbTFDeRuWTjm47upCBMDxuIKrs3q5UVtyA0tOlbIO3Lm7AoClmCoa_B7TchGz3Q69CGMrlXQbalRtMBD8lXmcTeF28sGpI8GY_j4uf52e37UV59e3LZbu8KnVFxFga2hMOmlSmkrpi0ADoXjFmbSV6CcLWRou-aTjDthfWSNr3hirVUGGM4YodFyez7zaG-x2ksdu4pGEYlIewSx3hFeWUCSn-jxLKOaWCs4yWM6pjSCmC7bbRbVR87AjupoK7ueBuLjjz7_fWuz7_60D_azQDH_aASloNNjegs_zAcSZlU9eZezdz6zSGeLjnX9FakIb9Af9du6A</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1126622763</pqid></control><display><type>article</type><title>Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine</title><source>Jstor Complete Legacy</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Uzicanin, Amra ; Thompson, Mark ; Smith, Peter ; Chaves, Sandra S. ; Foster, Lydia ; Dube, Nancy ; Graitcer, Samuel ; Jackson, Rebel ; Ferdinands, Jill ; Gargiullo, Paul ; Mills, Dora ; Monto, Arnold S. ; Shay, David K.</creator><creatorcontrib>Uzicanin, Amra ; Thompson, Mark ; Smith, Peter ; Chaves, Sandra S. ; Foster, Lydia ; Dube, Nancy ; Graitcer, Samuel ; Jackson, Rebel ; Ferdinands, Jill ; Gargiullo, Paul ; Mills, Dora ; Monto, Arnold S. ; Shay, David K. ; Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group ; on behalf of the Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</creatorcontrib><description>Background. In late October 2009, school-located pandemic vaccination was initiated in Maine before or concurrent with 2009 pandemic influenza A (H1N1) virus (pH1N1) peak activity. Methods. A case-control evaluation of 2009 H1N1 vaccine effectiveness was conducted in schools in Cumberland County, Maine. A case was a child who had an acute respiratory illness during 2 November-18 December 2009, and who tested positive for pH1N1 by real-time reverse-transcription polymerase chain reaction (rRT-PCR). For each case, ≥4 event time-matched controls were sampled among classmates present in school during the study period who did not have an influenza-like illness. Vaccine effectiveness was calculated as (1 - adjusted odds ratio [aOR]) × 100%; aOR was estimated by using weighted logistic regression. Results. After adjusting for a diagnosis of asthma, 1 dose of 2009 H1N1 vaccine provided 69% protection (95% confidence interval (CI), 13-89) against rRT-PCR-confirmed H1N1 infection. Vaccine effectiveness estimates for live attenuated and inactivated vaccine were 81% (95% CI, -37 to 97), and 58% (95% CI: -39 to 87), respectively. Conclusions. One dose of monovalent pandemic vaccine provided substantial protection against pH1N1 infection among school-aged children.</description><identifier>ISSN: 0022-1899</identifier><identifier>EISSN: 1537-6613</identifier><identifier>DOI: 10.1093/infdis/jis441</identifier><identifier>PMID: 22850120</identifier><identifier>CODEN: JIDIAQ</identifier><language>eng</language><publisher>Oxford: Oxford University Press</publisher><subject>Adolescent ; Applied microbiology ; Asthma ; Biological and medical sciences ; Case-Control Studies ; Child ; Child, Preschool ; Diseases ; Dosage ; Female ; Fundamental and applied biological sciences. Psychology ; H1N1 subtype influenza A virus ; Humans ; Infections ; Infectious diseases ; Influenza A virus ; Influenza A Virus, H1N1 Subtype - genetics ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza Vaccines - administration & dosage ; Influenza, Human - epidemiology ; Influenza, Human - immunology ; Influenza, Human - prevention & control ; Logistic Models ; Maine - epidemiology ; Male ; Medical sciences ; Microbiology ; Miscellaneous ; Pandemics ; Pandemics - prevention & control ; Registered nurses ; Reverse Transcriptase Polymerase Chain Reaction ; RNA, Viral - genetics ; School age children ; Treatment Outcome ; Vaccination ; Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) ; Vaccines, Attenuated - administration & dosage ; Virology ; VIRUSES</subject><ispartof>The Journal of infectious diseases, 2012-10, Vol.206 (7), p.1059-1068</ispartof><rights>Copyright © 2012 Oxford University Press on behalf of the Infectious Diseases Society of America</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-d2b16ec14d49c43e8eecba33ff47b9e7f5dc7b88630fb7fd92bbd2aa827ddd6a3</citedby><cites>FETCH-LOGICAL-c417t-d2b16ec14d49c43e8eecba33ff47b9e7f5dc7b88630fb7fd92bbd2aa827ddd6a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/41725718$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/41725718$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26399855$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22850120$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uzicanin, Amra</creatorcontrib><creatorcontrib>Thompson, Mark</creatorcontrib><creatorcontrib>Smith, Peter</creatorcontrib><creatorcontrib>Chaves, Sandra S.</creatorcontrib><creatorcontrib>Foster, Lydia</creatorcontrib><creatorcontrib>Dube, Nancy</creatorcontrib><creatorcontrib>Graitcer, Samuel</creatorcontrib><creatorcontrib>Jackson, Rebel</creatorcontrib><creatorcontrib>Ferdinands, Jill</creatorcontrib><creatorcontrib>Gargiullo, Paul</creatorcontrib><creatorcontrib>Mills, Dora</creatorcontrib><creatorcontrib>Monto, Arnold S.</creatorcontrib><creatorcontrib>Shay, David K.</creatorcontrib><creatorcontrib>Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</creatorcontrib><creatorcontrib>on behalf of the Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</creatorcontrib><title>Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine</title><title>The Journal of infectious diseases</title><addtitle>J Infect Dis</addtitle><description>Background. In late October 2009, school-located pandemic vaccination was initiated in Maine before or concurrent with 2009 pandemic influenza A (H1N1) virus (pH1N1) peak activity. Methods. A case-control evaluation of 2009 H1N1 vaccine effectiveness was conducted in schools in Cumberland County, Maine. A case was a child who had an acute respiratory illness during 2 November-18 December 2009, and who tested positive for pH1N1 by real-time reverse-transcription polymerase chain reaction (rRT-PCR). For each case, ≥4 event time-matched controls were sampled among classmates present in school during the study period who did not have an influenza-like illness. Vaccine effectiveness was calculated as (1 - adjusted odds ratio [aOR]) × 100%; aOR was estimated by using weighted logistic regression. Results. After adjusting for a diagnosis of asthma, 1 dose of 2009 H1N1 vaccine provided 69% protection (95% confidence interval (CI), 13-89) against rRT-PCR-confirmed H1N1 infection. Vaccine effectiveness estimates for live attenuated and inactivated vaccine were 81% (95% CI, -37 to 97), and 58% (95% CI: -39 to 87), respectively. Conclusions. One dose of monovalent pandemic vaccine provided substantial protection against pH1N1 infection among school-aged children.</description><subject>Adolescent</subject><subject>Applied microbiology</subject><subject>Asthma</subject><subject>Biological and medical sciences</subject><subject>Case-Control Studies</subject><subject>Child</subject><subject>Child, Preschool</subject><subject>Diseases</subject><subject>Dosage</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>H1N1 subtype influenza A virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Influenza A virus</subject><subject>Influenza A Virus, H1N1 Subtype - genetics</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza Vaccines - administration & dosage</subject><subject>Influenza, Human - epidemiology</subject><subject>Influenza, Human - immunology</subject><subject>Influenza, Human - prevention & control</subject><subject>Logistic Models</subject><subject>Maine - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Microbiology</subject><subject>Miscellaneous</subject><subject>Pandemics</subject><subject>Pandemics - prevention & control</subject><subject>Registered nurses</subject><subject>Reverse Transcriptase Polymerase Chain Reaction</subject><subject>RNA, Viral - genetics</subject><subject>School age children</subject><subject>Treatment Outcome</subject><subject>Vaccination</subject><subject>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</subject><subject>Vaccines, Attenuated - administration & dosage</subject><subject>Virology</subject><subject>VIRUSES</subject><issn>0022-1899</issn><issn>1537-6613</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU9v1DAQxSMEokvhyBHkC1I5hPpPYsfHVWhppRZQKVwjxx53vcraWztbqXy7fjMcsuyV04w0v_eeNK8o3hL8iWDJTp23xqXTtUtVRZ4VC1IzUXJO2PNigTGlJWmkPCpepbTGGFeMi5fFEaVNjQnFi-LpzFrQo3sADymhYBFBn0OCabv0dtiB_63QEp1ckK_kI6IYS3QdfHhQA_gR_VJau6xEzqPvEbLL6PwduslbTFDeRuWTjm47upCBMDxuIKrs3q5UVtyA0tOlbIO3Lm7AoClmCoa_B7TchGz3Q69CGMrlXQbalRtMBD8lXmcTeF28sGpI8GY_j4uf52e37UV59e3LZbu8KnVFxFga2hMOmlSmkrpi0ADoXjFmbSV6CcLWRou-aTjDthfWSNr3hirVUGGM4YodFyez7zaG-x2ksdu4pGEYlIewSx3hFeWUCSn-jxLKOaWCs4yWM6pjSCmC7bbRbVR87AjupoK7ueBuLjjz7_fWuz7_60D_azQDH_aASloNNjegs_zAcSZlU9eZezdz6zSGeLjnX9FakIb9Af9du6A</recordid><startdate>20121001</startdate><enddate>20121001</enddate><creator>Uzicanin, Amra</creator><creator>Thompson, Mark</creator><creator>Smith, Peter</creator><creator>Chaves, Sandra S.</creator><creator>Foster, Lydia</creator><creator>Dube, Nancy</creator><creator>Graitcer, Samuel</creator><creator>Jackson, Rebel</creator><creator>Ferdinands, Jill</creator><creator>Gargiullo, Paul</creator><creator>Mills, Dora</creator><creator>Monto, Arnold S.</creator><creator>Shay, David K.</creator><general>Oxford University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7T2</scope><scope>7U2</scope><scope>7U9</scope><scope>C1K</scope><scope>H94</scope></search><sort><creationdate>20121001</creationdate><title>Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine</title><author>Uzicanin, Amra ; Thompson, Mark ; Smith, Peter ; Chaves, Sandra S. ; Foster, Lydia ; Dube, Nancy ; Graitcer, Samuel ; Jackson, Rebel ; Ferdinands, Jill ; Gargiullo, Paul ; Mills, Dora ; Monto, Arnold S. ; Shay, David K.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-d2b16ec14d49c43e8eecba33ff47b9e7f5dc7b88630fb7fd92bbd2aa827ddd6a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Adolescent</topic><topic>Applied microbiology</topic><topic>Asthma</topic><topic>Biological and medical sciences</topic><topic>Case-Control Studies</topic><topic>Child</topic><topic>Child, Preschool</topic><topic>Diseases</topic><topic>Dosage</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>H1N1 subtype influenza A virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Influenza A virus</topic><topic>Influenza A Virus, H1N1 Subtype - genetics</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza Vaccines - administration & dosage</topic><topic>Influenza, Human - epidemiology</topic><topic>Influenza, Human - immunology</topic><topic>Influenza, Human - prevention & control</topic><topic>Logistic Models</topic><topic>Maine - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Microbiology</topic><topic>Miscellaneous</topic><topic>Pandemics</topic><topic>Pandemics - prevention & control</topic><topic>Registered nurses</topic><topic>Reverse Transcriptase Polymerase Chain Reaction</topic><topic>RNA, Viral - genetics</topic><topic>School age children</topic><topic>Treatment Outcome</topic><topic>Vaccination</topic><topic>Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects)</topic><topic>Vaccines, Attenuated - administration & dosage</topic><topic>Virology</topic><topic>VIRUSES</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uzicanin, Amra</creatorcontrib><creatorcontrib>Thompson, Mark</creatorcontrib><creatorcontrib>Smith, Peter</creatorcontrib><creatorcontrib>Chaves, Sandra S.</creatorcontrib><creatorcontrib>Foster, Lydia</creatorcontrib><creatorcontrib>Dube, Nancy</creatorcontrib><creatorcontrib>Graitcer, Samuel</creatorcontrib><creatorcontrib>Jackson, Rebel</creatorcontrib><creatorcontrib>Ferdinands, Jill</creatorcontrib><creatorcontrib>Gargiullo, Paul</creatorcontrib><creatorcontrib>Mills, Dora</creatorcontrib><creatorcontrib>Monto, Arnold S.</creatorcontrib><creatorcontrib>Shay, David K.</creatorcontrib><creatorcontrib>Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</creatorcontrib><creatorcontrib>on behalf of the Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Virology and AIDS Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>The Journal of infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uzicanin, Amra</au><au>Thompson, Mark</au><au>Smith, Peter</au><au>Chaves, Sandra S.</au><au>Foster, Lydia</au><au>Dube, Nancy</au><au>Graitcer, Samuel</au><au>Jackson, Rebel</au><au>Ferdinands, Jill</au><au>Gargiullo, Paul</au><au>Mills, Dora</au><au>Monto, Arnold S.</au><au>Shay, David K.</au><aucorp>Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</aucorp><aucorp>on behalf of the Maine 2009 Influenza A (H1N1) Vaccine Effectiveness Evaluation Group</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine</atitle><jtitle>The Journal of infectious diseases</jtitle><addtitle>J Infect Dis</addtitle><date>2012-10-01</date><risdate>2012</risdate><volume>206</volume><issue>7</issue><spage>1059</spage><epage>1068</epage><pages>1059-1068</pages><issn>0022-1899</issn><eissn>1537-6613</eissn><coden>JIDIAQ</coden><abstract>Background. In late October 2009, school-located pandemic vaccination was initiated in Maine before or concurrent with 2009 pandemic influenza A (H1N1) virus (pH1N1) peak activity. Methods. A case-control evaluation of 2009 H1N1 vaccine effectiveness was conducted in schools in Cumberland County, Maine. A case was a child who had an acute respiratory illness during 2 November-18 December 2009, and who tested positive for pH1N1 by real-time reverse-transcription polymerase chain reaction (rRT-PCR). For each case, ≥4 event time-matched controls were sampled among classmates present in school during the study period who did not have an influenza-like illness. Vaccine effectiveness was calculated as (1 - adjusted odds ratio [aOR]) × 100%; aOR was estimated by using weighted logistic regression. Results. After adjusting for a diagnosis of asthma, 1 dose of 2009 H1N1 vaccine provided 69% protection (95% confidence interval (CI), 13-89) against rRT-PCR-confirmed H1N1 infection. Vaccine effectiveness estimates for live attenuated and inactivated vaccine were 81% (95% CI, -37 to 97), and 58% (95% CI: -39 to 87), respectively. Conclusions. One dose of monovalent pandemic vaccine provided substantial protection against pH1N1 infection among school-aged children.</abstract><cop>Oxford</cop><pub>Oxford University Press</pub><pmid>22850120</pmid><doi>10.1093/infdis/jis441</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0022-1899 |
| ispartof | The Journal of infectious diseases, 2012-10, Vol.206 (7), p.1059-1068 |
| issn | 0022-1899 1537-6613 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1642623797 |
| source | Jstor Complete Legacy; Oxford University Press Journals All Titles (1996-Current); MEDLINE; Alma/SFX Local Collection |
| subjects | Adolescent Applied microbiology Asthma Biological and medical sciences Case-Control Studies Child Child, Preschool Diseases Dosage Female Fundamental and applied biological sciences. Psychology H1N1 subtype influenza A virus Humans Infections Infectious diseases Influenza A virus Influenza A Virus, H1N1 Subtype - genetics Influenza A Virus, H1N1 Subtype - immunology Influenza Vaccines - administration & dosage Influenza, Human - epidemiology Influenza, Human - immunology Influenza, Human - prevention & control Logistic Models Maine - epidemiology Male Medical sciences Microbiology Miscellaneous Pandemics Pandemics - prevention & control Registered nurses Reverse Transcriptase Polymerase Chain Reaction RNA, Viral - genetics School age children Treatment Outcome Vaccination Vaccines, antisera, therapeutical immunoglobulins and monoclonal antibodies (general aspects) Vaccines, Attenuated - administration & dosage Virology VIRUSES |
| title | Effectiveness of 1 Dose of Influenza A (H1N1) 2009 Monovalent Vaccines in Preventing Reverse-Transcription Polymerase Chain Reaction-Confirmed H1N1 Infection Among School-Aged Children in Maine |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A37%3A41IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effectiveness%20of%201%20Dose%20of%20Influenza%20A%20(H1N1)%202009%20Monovalent%20Vaccines%20in%20Preventing%20Reverse-Transcription%20Polymerase%20Chain%20Reaction-Confirmed%20H1N1%20Infection%20Among%20School-Aged%20Children%20in%20Maine&rft.jtitle=The%20Journal%20of%20infectious%20diseases&rft.au=Uzicanin,%20Amra&rft.aucorp=Maine%202009%20Influenza%20A%20(H1N1)%20Vaccine%20Effectiveness%20Evaluation%20Group&rft.date=2012-10-01&rft.volume=206&rft.issue=7&rft.spage=1059&rft.epage=1068&rft.pages=1059-1068&rft.issn=0022-1899&rft.eissn=1537-6613&rft.coden=JIDIAQ&rft_id=info:doi/10.1093/infdis/jis441&rft_dat=%3Cjstor_proqu%3E41725718%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1126622763&rft_id=info:pmid/22850120&rft_jstor_id=41725718&rfr_iscdi=true |